Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3171711000168111 | Praluent (alirocumab 150 mg / 1 mL) injection, 1 x 1 mL pen device (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3171721000168116 | Praluent 150 mg/mL injection, 1 mL pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praluent 150 mg/mL injection, 1 mL pen device | Is a | trade product pack | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, 1 mL pen device | Is a | alirocumab 150 mg/mL injection, 1 mL pen device | true | Inferred relationship | Some | ||
| Praluent 150 mg/mL injection, 1 mL pen device | has TPUU | Praluent 150 mg/mL injection, pen device | true | Inferred relationship | Some | 1 | |
| Praluent 150 mg/mL injection, 1 mL pen device | has TP | Praluent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praluent 150 mg/mL injection, 1 mL pen device | Is a | True | Praluent 150 mg/mL injection, 1 mL pen device | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR